Answers are grounded in this paper and cite their sources.
Introduction. Venous thrombosis is etiopathogenetically associated with various pathologies characterized by an excessive tendency of the body to thrombosis in blood vessels. One of the types of disorders in the hemostasis system is venous thrombosis that occurs during pregnancy in women, which can lead to various gestational complications. Therefore, it is important to understand the etiopathogenesis of this pathological condition, including the contribution of hereditary factors. Objective. To analyze the association of 8 genetic variants of the hemostasis system genes and 4 folate metabolism genes with venous thrombosis in women that occurred during gestation. Materials and methods. The study included 311 women aged 20 to 38 years, who were diagnosed with gestational venous thrombosis of various localizations during gestation, and 225 women in the control group. The study of the genotypes of the selected genetic variants was carried out by real-time PCR with melting curve analysis. Results. A positive association was found for 4 genetic variants: F2 c.20210G>A (OR=11.03, CI: 2.60—46.81, p<0.001); F5 c.1691G>A (OR=6.02, CI: 2.52—14.38, p<0.001); FGB c.–455 G>A (OR=5.65, CI: 3.05—10.45, p<0.001) and PAI-1 c.–675 5G>4G(OR=2.28, CI: 1.54—3.39, p<0.001). Conclusion. Thus, we established an association of 4 genetic variants of plasma hemostatic factor genes with hereditary predisposition to venous thrombosis in women during pregnancy.
No takes yet. Share an insight, caveat, or question.
Perevesentsev et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: